rabeprazole has been researched along with Aerophagy in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Aerophagy: Spasmodic swallowing of air.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zentilin, P | 1 |
| Accornero, L | 1 |
| Dulbecco, P | 1 |
| Savarino, E | 1 |
| Savarino, V | 1 |
1 other study available for rabeprazole and Aerophagy
| Article | Year |
|---|---|
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aerophagy; Anti-Ulcer Agents; Benzimidazoles; Dose-R | 2005 |